BridgeBio Pharma Overview
BridgeBio Pharma Target Price
Analysts' 12-month price predictions for BBIO.
Get informed when a big investor buys or sells
+ FollowShare Price
$69.38
Average Target Price
$104.70
50.9% upside
50.9% upside10 analysts in the last 4 months
High: $130 | Low: $95
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-16 | Mizuho SecuritiesSalim Syed | $96 | 38.4% upside |  |
| 2026-06-03 | Canaccord Genuity | $104 | 49.9% upside | |
| 2026-05-28 | Morgan Stanley | $98 | 41.3% upside | |
| 2026-05-11 | H.C. Wainwright | $110 | 58.5% upside | |
| 2026-05-08 | Evercore ISI | $130 | 87.4% upside | |
| 2026-05-08 | Bernstein | $114 | 64.3% upside | |
| 2026-04-29 | Truist FinancialDanielle Brill | $102 | 47% upside | |
| 2026-04-08 | RBC CapitalLuca Issi | $100 | 44.1% upside | |
| 2026-03-12 | Leerink PartnersMani Foroohar | $98 | 41.3% upside | |
| 2026-02-25 | Truist FinancialDanielle Brill | $95 | 36.9% upside | |
| 2026-02-17 | H.C. WainwrightRaghuram Selvaraju | $100 | 44.1% upside | |
| 2026-02-13 | Tudor PickeringWilliam Pickering | $100 | 44.1% upside | |
| 2026-02-13 | OppenheimerTrevor Allred | $83 | 19.6% upside | |
| 2026-02-12 | JefferiesAndrew Tsai | $100 | 44.1% upside | |
| 2026-02-12 | Raymond JamesMartin Auster | $89 | 28.3% upside | |
| 2026-01-27 | Barclays | $157 | 126.3% upside | |
| 2026-01-20 | Wells FargoTiago Fauth | $88 | 26.8% upside | |
| 2026-01-08 | Truist Financial | $86 | 24% upside | |
| 2026-01-06 | Morgan Stanley | $96 | 38.4% upside | |
| 2025-12-15 | Leerink Partners | $86 | 24% upside | |
| 2025-12-11 | Bernstein | $94 | 35.5% upside | |
| 2025-10-30 | Truist Financial | $80 | 15.3% upside | |
| 2025-10-30 | Oppenheimer | $81 | 16.7% upside | |
| 2025-10-30 | Piper Sandler | $98 | 41.3% upside | |
| 2025-10-30 | Goldman SachsPaul Choi | $100 | 44.1% upside | |
| 2025-10-29 | H.C. Wainwright | $90 | 29.7% upside | |
| 2025-10-28 | H.C. Wainwright | $80 | 15.3% upside | |
| 2025-10-27 | Raymond James | $69 |  0.5% downside | |
| 2025-10-27 | Leerink PartnersMani Foroohar | $68 | 2% downside | |
| 2025-08-29 | H.C. WainwrightRaghuram Selvaraju | $70 | 0.9% upside | |
| 2025-04-30 | UBSEliana Merle | $72 | 3.8% upside | |
| 2024-10-24 | CitigroupDavid Lebowitz | $45 | 35.1% downside | |
| 2024-10-17 | Leerink PartnersMani Foroohar | $46 | 33.7% downside | |
| 2024-09-11 | Piper SandlerBiren Amin | $46 | 33.7% downside | |
| 2024-09-03 | Mizuho SecuritiesSalim Syed | $53 | 23.6% downside | |
| 2024-06-24 | Raymond JamesDanielle Brill | $46 | 33.7% downside | |
| 2024-06-05 | BMO CapitalKostas Biliouris | $37 | 46.7% downside | |
| 2024-06-05 | Wells FargoTiago Fauth | $58 | 16.4% downside | |
| 2024-05-30 | Goldman SachsPaul Choi | $50 | 27.9% downside | |
| 2024-05-28 | UBSEliana Merle | $47 | 32.3% downside | |
| 2024-05-20 | H.C. WainwrightRaghuram Selvaraju | $43 | 38% downside | |
| 2024-05-13 | Evercore ISICory Kasimov | $50 | 27.9% downside | |
| 2022-11-18 | J.P. Morgan | $19 | 72.6% downside | |
| 2022-03-17 | Raymond JamesDane Leone | $17 | 75.5% downside | |